← All trials
NCT04452474
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 30, 2020
- Primary completion
- Nov 16, 2020
- Completion date
- Jan 29, 2021
- First posted
- Jun 30, 2020
- Last posted
- Jun 30, 2020
- Enrollment
- 376
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- R-PharmLead sponsor
- Cromos Pharma, LLCCollaborator
- CovanceCollaborator
- R-PharmStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.